Metabolon Launches Splash and Ripple Bioinformatics Application
Metabolon, Inc. has released Splash and Ripple, a bioinformatics application designed to translate metabolomic biomarkers into candidate protein mechanisms. The tool operates within the company’s Integrated Bioinformatics Platform to help researchers connect biochemical changes to specific enzymes, transporters, receptors, and binding proteins.
Metabolomics measures biochemical activity close to phenotype, capturing the combined effects of genes, protein activity, disease, treatment, and environmental influences. However, this proximity often creates complex interpretation challenges. A changed metabolite may be associated with numerous enzymes, transporters, receptors, and binding proteins, forcing researchers into months of manual research across scientific literature, biological databases, and multiple omics datasets to form focused mechanistic hypotheses.
MAP Database Connects Metabolites to Relevant Proteins
Splash and Ripple relies on Metabolon’s proprietary Metabolite Affiliated Proteins (MAP) Database, an exclusive, scientist-curated knowledge resource connecting measured metabolites to relevant proteins. The software applies advanced network algorithms to these curated relationships to identify proteins closely associated with observed biochemical changes. Researchers can examine the evidence behind each relationship and prioritize candidate proteins based on the strength and concentration of supporting metabolite evidence.
The application features an interactive interface that allows users to move between biomarkers, candidate proteins, and supporting network relationships. This single exploratory environment replaces traditional, broader pathway enrichment analyses that often provide broad biological context without identifying the specific mechanisms researchers should investigate next.
Optional Artificial Intelligence Interpretation
The platform includes an optional AI-assisted interpretation module that evaluates promising protein-metabolite relationships against literature, genetic associations, interaction evidence, and phenotypic context. This module generates citation-supported hypotheses for scientific review.
Organizations with project requirements that restrict AI usage can operate Splash and Ripple without the artificial intelligence component. In both configurations, the application supports hypothesis generation and experimental validation rather than establishing causality.
Splash & Ripple enables scientists to explore candidate protein mechanisms immediately, understand why they have been prioritized, and develop more focused multiomic hypotheses,
said Ro Hastie, President and CEO of Metabolon, regarding the launch.
Platform Integrates Multiomics Data with Scientific Services
Splash and Ripple integrates metabolomics data with genomic, transcriptomic, proteomic, clinical, and other biological data inside Metabolon’s broader platform. Users also gain access to Metabolon’s scientific services team to evaluate hypotheses, assess supporting evidence, and translate findings into actionable research plans based on project needs and scope.
Frequently Asked Questions About Splash and Ripple
What core database powers the Splash and Ripple application?
The software is built on Metabolon’s proprietary Metabolite Affiliated Proteins (MAP) Database, which connects measured metabolites to enzymes, transporters, receptors, and binding proteins.
Can organizations use the application without artificial intelligence features?
Yes. The AI-assisted interpretation module is completely optional, allowing organizations with restrictions on AI usage to run core network analyses independently.
What type of data output does the application generate?
Splash and Ripple generates candidate protein mechanisms and citation-supported hypotheses designed to assist researchers in prioritizing downstream experiments rather than establishing causality.
Keep reading